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a b s t r a c t
Goniothalamin, a styryllactone, has been shown to induce cytotoxicity via apoptosis in several tumor cell
lines. In this study, we have examined the potential role of several genes, which were stably transfected
into T-cell lines and which regulate apoptosis in different ways, on goniothalamin-induced cell death.
Overexpression of full-length receptor for activated protein C-kinase 1 (RACK-1) and pc3n3, which up-
regulates endogenous RACK-1, in both Jurkat and W7.2 T cells resulted in inhibition of goniothalamin-
induced cell death as assessed byMTT and clonogenic assays. However, overexpression of rFau (antisense
sequence to Finkel–Biskis–Reilly murine sarcoma virus-associated ubiquitously expressed gene) in W7.2
cells did not confer resistance to goniothalamin-induced cell death. Etoposide, a clinically used cytotoxic
agent, was equipotent in causing cytotoxicity in all the stable transfectants. Assessment of DNA damageDNA damage
Cell death by Comet assay revealed goniothalamin-induced DNA strand breaks as early as 1h in vector control but
this effect was inhibited in RACK-1 and pc3n3 stably transfected W7.2 cells. This data demonstrate that
RACK-1 plays a crucial role in regulating cell death signalling pathways induced by goniothalamin.
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d. Introduction
Given the molecular complexity of the cell death processes,
pproaches for therapeutic intervention include development of
mallmolecules fromeither combinatorial chemistry or fromnatu-
al products tomodulate death regulators. Clearly, natural products
erve as an important source of chemical structural diversity and
ave been the mainstay of the discovery of new leads for cytotoxic
rugs in the past 25 years (Cragg and Newman, 2003).
Styryllactones are a group of secondary metabolites found
biquitously in Goniothalamus plant species. To date, there are
pproximately 100 styryllactones, including synthetic analogs and
ome of these compounds have been demonstrated to show
harmacological properties such as anticancer, anti-inﬂammation,
mmunosuppressive and antiparasitic activities (de Fátima et al.,
006a). Since styryllactones have structural similarity with stil-
enes and the fact that many stilbenes have been patented for drug
evelopment (Inayat-Hussain and Thomas, 2004), it is envisaged
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that there will be an increase in drug development of novel anti-
cancer compounds incorporating stilbene and lactone moieties in
the future. In this respect, goniothalamin (GTN) a plant styryllac-
tone isolated from Goniothalamus andersonii, induces cytotoxicity
in a variety of cancer cell lines including cervical (Hela), gastric
(HGC-27), kidney (786-0), breast carcinomas (MCF7, T47D and
MDA-MB-231) and leukemia (HL-60, Jurkat and CEM-SS) (Ali et al.,
1997; Inayat-Hussain et al., 1999, 2003; Pihie et al., 1998; Rajab
et al., 2005; Chen et al., 2005; de Fátima et al., 2006b). Our group
and others have demonstrated that cytotoxicity of GTN in human
leukemia (HL-60 and Jurkat) and human breast cancer cells (MDA-
MB-231)occursviaapoptotic cell death (Inayat-Hussainet al., 1999,
2003; Chen et al., 2005). Intracellular redox status disruption and
DNA damage are early signals for cell death prior to loss of mito-
chondrial membrane potential and activation of the apical caspase
9. However, the precise molecular regulation of cell death induced
by goniothalamin is not fully understood.
Advances in cDNA library based functional expression cloning
have led to the discovery of novel genes which regulate cell
Open access under CC BY license. death through apoptosis (Williams and Farzaneh, 2004). Our group
and others have successfully identiﬁed novel apoptotic control-
ling genes including LUCA15/RBM5 a novel tumor suppressor
gene (Sutherland et al., 2000), fau (Finkel–Biskis–Reilly murine
sarcoma virus (FBR-MuSV) associated ubiquitously expressed
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ene) (Mourtada-Maarabouni et al., 2003), vATPase (Anderson
nd Williams, 2003), protein phosphatase 4 (PP4) (Mourtada-
aarabouni et al., 2003), Toso (Hitoshi et al., 1998) and RACK-1
Mourtada-Maarabouni et al., 2005). It has been shown that the
au antisense sequence (rFau) suppresses apoptosis induced by
isplatin, ultraviolet (UV) radiation and dexamethasone. Similarly,
ells overexpressing thepartial sequenceofPP4 (4n10) are resistant
o the induction of cell death by dexamethasone and UV radiation
Mourtada-Maarabouni et al., 2003).
In recent years, accumulating evidence has demonstrated that
everal kinase signalling cascades can result in regulated cell death
Horbinski and Chu, 2005). Amongst these, the protein kinase
family, which consists of multiple isozymes, plays a pivotal
ole in cell death, cell growth and differentiation (Fields and
urray, 2008). Localisation of PKCs to speciﬁc cellular compart-
ents involves the receptor for activated C-kinase 1 (RACK-1).
ACK-1, a multiple WD motif-containing protein, is important
n regulating cell growth by suppressing apoptosis (Mourtada-
aarabouni et al., 2005). Choi et al. (2003) have shown that
ACK-1 gene expression is induced by NF-B leading to cell sur-
ival of PC-12 cells upon withdrawal of nerve growth factor.
onsistentwith this, RACK-1overexpression relieves EIA-mediated
rowth inhibition, protects SAOS-2 tumor cells (Sang et al.,
001) and produces resistance to dexamethasone and UV-induced
poptosis in W7.2 thymoma cells (Mourtada-Maarabouni et al.,
005).
Since RACK-1, rFau and 4n.10 result in cell survival induced by
NA damaging agents including cisplatin and UV radiation, there-
ore itwill be important to investigate the effects of GTNwhich also
nduces DNA damage leading to cytotoxicity. To test the hypoth-
sis that GTN-induced cytotoxicity is regulated by RACK-1, rFau
nd 4n.10, we investigated the effects of GTN on a panel of T-
ell lines with speciﬁc blocks to the induction of cell death. These
uman and mouse T-cell clones overexpress RACK-1, pc3n3 (par-
ial sequence of RACK-1), rFau and 4n.10. This study demonstrates
hat only overexpression of RACK-1 and pc3n3 protects against
oniothalamin-induced cell death.
. Materials and methods
.1. Chemicals
GTN was obtained as described previously (Chan et al., 2006). Etoposide was
urchased from Sigma–Aldrich.
.2. Cell culture
The apoptosis-sensitive clone W7.2, originally derived from mouse thymoma
ine WEHI-105.726 (Longthorne and Williams, 1997), and the cloned human
eukaemic cell line Jurkat.JKM1 were maintained in RPMI-1640 medium (Sigma)
upplemented with 10% heat inactivated fetal calf serum (Hyclone), 2mM L-
lutamine and 200g/ml gentamycin (Sigma), at 37 ◦C in a 5% CO2 humidiﬁed
ncubator.
.3. Establishment of stable clones
The generation of the constructs pcDNA3.1/pc3n3, pcDNA3/rfau and
cDNA3/4n.10 in expression vectors and the establishment of stable clones express-
ng these constructs have been previously described (Mourtada-Maarabouni et
l., 2004, 2005). The production of stable transfectants of RACK-1 (1dbEST Id:
3833312, GeneBank Acc: BU515312; IMAGE: 6511980) has been described in
ourtada-Maarabouni et al. (2005).
.4. Clonogenic assay
Survival of control and treated cells was also assessed by the ability of the cells
o form colonies in soft agar (based on Longthorne and Williams, 1997). Essentially,
×103 Jurkat cells and 5×104 W7.2 cells were treated with 5M GTN. An equal
roportion of the culture from each experimental condition was diluted in 5ml
scove’smedium(Sigma) containing20%heat inactivated fetal calf serum,10%W7.2-
r Jurkat-conditioned medium and 0.3% Noble agar (Difco) and plated in 60mm
ishes. Dishes were also overlaid with 2.5ml Iscove’s complete medium containingy Letters 191 (2009) 118–122 119
10% cell-conditioned medium. The cells were left for 16 days incubation at 37 ◦C in
5% CO2 and the number of colonies formed was counted.
2.5. Western blot analysis
Samples (1×106 cells) were mixed with Laemmli’s loading buffer and sub-
jected to 10% SDS-PAGE and transferred onto a PVDF membrane. The blots were
then probed with the anti-RACK-1 (1:2500 dilution; clone 20, BD Transduction Lab-
oratories, #R20620), or anti--actin antibody (dilution 1:5000; Sigma, #A5441),
followedby the appropriate horseradish peroxidase-conjugated secondary antibod-
ies. The secondary antibodies used were anti–mouse IgM (diluted 1:1000; Santa
Cruz, #sc2064) and anti-mouse immunoglobulin (diluted 1:800; Dakko, #P0447).
2.6. Alkaline Comet assay
The Comet assay was carried out as described previously (Rajab et al., 2005).
Brieﬂy, cells (1×106 cells/ml) were treated in 6 well plates with 5M GTN for 1h.
Analysis was carried out with a ﬂuorescence microscope and DNA damage was
assessed in 50 cells where tail moment was quantiﬁed using the Comet Assay III
(Perceptive Instrument Ltd).
2.7. MTT assay
Cytotoxicity of GTN was evaluated using the MTT assay. Based on our previous
study, a range of concentrations (from 5 to 150M) was used and these concen-
trations were demonstrated to exhibit a concentration-dependent increase of cell
death in Jurkat T cells (Inayat-Hussain et al., 1999). Brieﬂy, cells were treated at
1×106 cells/ml with ﬁnal concentrations of 12.5, 25, 50 and 100M GTN. After
24h incubation, 20l of 5mg/ml MTT (Sigma) solution was added to each well
and further incubated for 4h at 37 ◦C. Subsequently, 150l medium was discarded
from each well before adding 150l DMSO (Fischer Scientiﬁc). The cytotoxic effects
of GTN were detected by measuring the absorbance of each well at 570nm and
calculated as described previously (Chen et al., 2005).
2.8. Statistical analysis
The data were presented as the means± standard error of the means (S.E.M.).
Statistical analysiswasperformedwith Student’s t-test for comparisonbetween two
means. One-way ANOVA with Tukey post hoc test was used to test the signiﬁcance
between multiple means. A p-value of <0.05 was considered statistically signiﬁcant.
3. Results
3.1. Characterization of GTN-induced cytotoxicity in
apoptosis-resistant cell lines
To investigate the effects of GTN on cells expressing known
apoptosis-resistance genes, stably transfected Jurkat and W7.2 T-
cells were employed. Cytotoxicity was assessed using the MTT
assay and the IC50 of GTN in the various cells after 24h treat-
ment was determined as shown in Fig. 1A. The IC50 for wt Jurkat
was 21±1M which was similar to the IC50 for the vector control
(20±0.5M). In contrast, there was a signiﬁcant increase in the
IC50 of RACK-1 overexpressing Jurkat cells (33±1M).
In order to conﬁrm the observation in the Jurkat cells, a panel
of W7.2 T cell lines was also employed (Fig. 1B). GTN treatment
of wt W7.2 cells resulted in cytotoxicity with an IC50 of 12±1M
conﬁrming that thesemouse cellsweremore sensitive than human
Jurkat cells. In agreement with the Jurkat RACK-1 data, GTN treat-
ment of W7.2 cells overexpressing RACK-1 (IC50 =16±0.1M)
revealed resistance to GTN compared to the IC50 of the vector
control cells (8.5±0.3M). Resistance to cytotoxicity was also
observed in cells transfected with pc3n3, which increases endoge-
nous RACK-1 levels (Mourtada-Maarabouni et al., 2005), where the
IC50 was 13±0.5M. However, GTN cytotoxicity was not affected
in rFau and 4n10 stable transfectants where the IC50 values were
7±0.3 and 10±0.4M, respectively.
To conﬁrm the speciﬁcity of the effects observed with GTN,
we analysed the effects of topoisomerase II inhibitor etoposide in
both panels of cells. As shown in Fig. 2A, etoposide treated RACK-1
overexpressing Jurkat cells showed an IC50 of 10±0.4M which is
lower than the IC50 of the vector control (13±1M) conﬁrming no
resistance by RACK-1. Similarly, treatment with etoposide did not
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cell lines (HL-60 and CEM-SS), MDA-MB231 breast cancer cells and
vascular smooth muscle cells (Rajab et al., 2005; Chan et al., 2006;ig. 1. The IC50s of GTN treated Jurkat cells (panel A) and W7.2 cells (panel B). Cells
1×106 cells/ml) were treated with various concentrations of GTN (0–100M) for
4h before cytotoxicity was evaluated using MTT assay. Cumulative data represent
he mean± SEM of three separate experiments (*p<0.05 against vector control).eveal any reduction in cytotoxicity in the RACK-1 overexpressing
7.2 cells, where the IC50 was 7±0.7M compared to the vector
ontrol cells (8±0.6M). Furthermore, rFau overexpressing W7.2
ells did not show any increased cytotoxicity to etoposide treat-
ent (Fig. 2B). Since signiﬁcant inhibition of GTN cytotoxicity was
ig. 2. The IC50s of etoposide treated Jurkat cells (panel A) and W7.2 cells (panel
). Cells (1×106 cells/ml) were treated with various concentrations of etoposide
0–100M) for 24h before cytotoxicity was evaluated using MTT assay. Cumula-
ive data represent the mean± SEM of three separate experiments (*p<0.05 against
ector control).y Letters 191 (2009) 118–122
only observed in pc3n3 and RACK-1 stable transfectants, further
experiments were performed only in these cells.
3.2. Clonogenic assessment using soft agar colony formation
To ascertain the colony-forming ability of GTN treated cells,
clonogenic assessment of a panel of Jurkat and W7.2 stable trans-
fectantswas carried out in soft agar. Selection of GTN concentration
was based on preliminary studies using 2.5–10M GTN (data not
shown). Colony-forming ability was best assessed with 5M GTN
treatment for 16 days as shown in Fig. 3A. In agreement with the
MTT cytotoxicity data (see Fig. 1A), the clonogenic assay also con-
ﬁrmed that RACK-1 protected against cytotoxicity induced by GTN
in both Jurkat and W7.2 cells. There was an increase of 30 colonies
in Jurkat RACK-1 cells over vector control cells and very signiﬁ-
cant protection was detectable in W7.2 RACK-1 cells where more
than 500 colonies were observed in the presence of GTN (Fig. 3B).
In addition, the partial sequence of RACK-1 (pc3n3) also protected
against GTN-induced cytotoxicity in W7.2 cells where more than
17 colonies were observed, further strengthening the critical role
of RACK-1 in the induction of cell death by GTN. Immunoblotting
of RACK-1 protein expression in W7.2 and Jurkat cells conﬁrmed
the overexpression of RACK-1 in the stable transfectants express-
ing the full sequence of RACK-1 or its partial sequence (pc3n3)
(Fig. 4).
3.3. Assessment of DNA damage by Comet assay
GTN has been demonstrated to cause DNA damage in leukemiaUmar-Tsafe et al., 2004). In this study, the alkaline Comet assaywas
used to determine whether GTN could induce DNA damage in the
panel of T cells. As shown in Fig. 5A, GTN did not induce DNA dam-
Fig. 3. Clonogenic assessment followingGTN treatment on Jurkat cells (panel A) and
W7.2 cells (panel B). 1×103 Jurkat cells and 5×104 W7.2 cells were treated with
5MGTNand thecellswere left for a16-day incubation.Data representmean± SEM
from three independent experiments (*p<0.05 against vector control).
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Fig. 4. Protein expression of RACK-1 in Jurkat and W7.2 cells. Western blotting of
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cACK-1 protein in (a) Jurkat vector control (pcDNA3.1) and Jurkat RACK-1 and (b)
7.2 vector control (pcDNA3.1), W7.2-pc3n3 and W7.2 RACK-1 transfected clones.
he corresponding Western blots with anti--actin antibody are shown to demon-
trate equivalent loadings.
ge in wt, vector control and RACK-1 overexpressing Jurkat cells at
oncentrations used in the soft agar cloning assay (5M).However,
n W7.2 cells, GTN did induce DNA damage in the wt and more sig-
iﬁcantly in the vector control cells (Fig. 5B). Interestingly, in the
anel of W7.2 cells overexpressing the partial sequence to RACK-1
ig. 5. DNA damaging effects of GTN treated Jurkat cells (panel A) and W7.2 (panel
). 1×106 cellswere treatedwith5MGTNfor1hprior toComet analysis.Data rep-
esent mean± SEM from three independent experiments (*p<0.05 against vector
ontrol, #p<0.05 against vehicle control).Fig. 6. Schematic presentation of RACK-1 regulation in GTN-induced cytotoxicity.
RACK-1 has also been demonstrated to regulate UV radiation and dexamethasone
induced cytotoxicity. However, the effects of speciﬁc kinases in this model is yet to
be identiﬁed.
(pc3n3) and RACK-1, no DNA damage was observed, suggesting a
protection by these genes.
4. Discussion
Using a panel of T-cell lines where the cell death pathway has
been genetically inhibited at speciﬁc stages, we tested whether
GTN’s toxicity was affected in these cells. Our data demonstrate
thatGTN cytotoxicitywas not inhibited by rFau stable transfectants
although overexpression of rFau suppresses cell death induced by
UV radiation and cisplatin in W7.2 cells (Mourtada-Maarabouni et
al., 2004). Similarly, etoposide treated rFau overexpressing W7.2
cells did not show any resistance to cell death as compared to the
vector control cells. It is interesting to note that Bcl-2 blocks cell
death induced by the expression of fau in the sense orientation
(Mourtada-Maarabouni et al., 2004). Fau contains a ubiquitin-like
polypeptide called FUBI which has been shown to bind Bcl-G. This
is consistentwith a recent study byWang et al. (2008)who demon-
strated that cisplatin down-regulates Bcl-2 by dephosphorylation
and ubiquitination leading to its proteosomal degradation. It will
be interesting to investigate whether Bcl-2 plays a role in GTN
cytotoxicity.
4n.10, thepartial sequenceof PP4which is amemberof thePP2A
family of serine/threonine protein phosphatases down-regulates
endogenous PP4 resulting in cell death (Mourtada-Maarabouni et
al., 2003). Emerging evidence indicates that PP4 may play impor-
tant and complex roles in apoptosis and cell proliferation especially
in T-cells (Mourtada-Maarabouni and Williams, 2008, 2009). Since
GTN-induced cytotoxicity was not affected when PP4 was down-
regulated in 4n.10 stable transfectants, this result implies that PP4
may not regulate cell survival or death induced by this natural
product.
Our data demonstrate that overexpression of RACK-1 in Jurkat
and W7.2 cells protected against GTN-induced cell death as
assessed by both MTT and soft agar colony-forming assays. RACK-1
is one of the adaptor proteins involved in molecular signalling by
binding to protein kinase C, leading to its activation (Schechtman
andMochly-Rosen, 2001). ThismultipleWD-motif-containing pro-
tein has beendemonstrated to activate JNKvia PKC, thus promoting
melanomagrowth innudemice (Lopez-Bergamietal., 2005).RACK-
1 also rescues adenoviral EIA-induced SAOS-2 cells apoptosis (Sang
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t al., 2001). Binding of RACK-1 to p73 but not p53 has been demon-
trated to prevent apoptosis in SAOS-2 cells (Ozaki et al., 2003). p73
unctions in a pathway mediating p53-independent cell death pro-
uced by cytotoxic drugs especially in p53-null cells such as Jurkat
Karpinich et al., 2006). Indeed, etoposide treatment of Jurkat cells
auses an increase in phosphorylation of p73, resulting in apop-
osis as early as 45min after treatment (Karpinich et al., 2006).
imilarly, another genotoxic stress-inducing agent, cis-platinum
esults in p73 elevation in CHO cells which is inhibited by RACK-
(Mor et al., 2008). Therefore it might be expected that RACK-1
verexpressing Jurkat cells would also be resistant to etoposide as
ACK-1 can inactivatep73.However, our study showsnodifference
n the IC50 of etoposide in RACK-1 overexpressing Jurkat and W7.2
ells compared to the vector control cells. These intriguing results
ay be attributed to the possible interaction of pRB which has
een demonstrated to physically bind RACK-1, thus diminishing
he RACK-1-dependent inhibition of p73 (Ozaki et al., 2003). Taken
ogether, current ﬁndings on RACK-1 suggest that this protein can
escue cells from the effects of only some genotoxic agents. Simi-
ar to UV radiation and dexamethasone (Mourtada-Maarabouni et
l., 2005), evidence from our current work demonstrates that, in
ddition to RACK-1, pc3n3, which up-regulates endogenous RACK-
, also confer resistance to GTN-induced cytotoxicity in Jurkat
nd W7.2 cells (Fig. 6). It is interesting to note that the type of
NA damage may play a role in resistance to RACK-1. Goniothala-
in, unlike etoposide, does not inhibit topoisomerase II (data not
hown). As GTN has been shown to modulate the redox status in
DA-MB 231 cells (Chen et al., 2005), it is tempting to speculate
hat highly reactive intermediates of GN such as epoxide deriva-
ives (probably goniothalamin epoxide) from phase I xenobiotic
etabolism may occur and can also conjugate to GSH and damage
he DNA via adduction. The molecular cross-talk between RACK-1
nd other putative proteins leading to inhibition of DNA damage
nd cytotoxicity warrants further investigation. Although it is pos-
ible that RACK-1 expression could protect cells from GTN-induced
uppression of proliferation, this is likely to be a relatively minor
omponent since ﬁrstly the very substantial protective effects of
ACK-1 in the colony-forming assay was produced at 5M, a con-
entration which has only a small effect on proliferation (data not
hown). Secondly, colonies appear at the same rate in plates con-
aining cells with and without RACK-1.
In conclusion, our data demonstrate that overexpression of
ACK-1 and pc3n3 which upregulates the endogenous RACK-1,
rotects against GTN-induced cell death leading to increased cell
urvival.
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